We are so used to hearing about the hurdles, delays and frustrating steps being taken by companies to move devices forward.

I was floored, and excited to spend the last 2.5 hours speaking with Ed Damiano who designed the algorithms for the AP. he showed me the next generation AP, which is going to be run off of an iPhone.

The front side shows the iPhone. The second photo shows the back of the case, which is the new generation Dexcom G4. A closed loop system that can fit in my pocket. NEXT GENERATION!

He is submitting it to the FDA in 3 weeks for approval to use in the next phase of his AP research studies.

By the numbers:
Less than 1% of blood glucose lower than 70 on the AP
Easily keep A1c’s between 6.5 and 7 for adults and 7 and 7.5 for kids.

He plans on having a small AP available on the market within 5 years, when his son goes to college.

He was not in the diabetes world when his son was diagnosed at 11 months of age. He is determined to solve the T1D problem of lack of care free management.

First AP meal. Let’s see what happens.

Sorry for the delay, I just spent the last 2.5 hours talking with the head of the study. More about that in a minute (or 2, it’s dinner time)

It reads the blood glucose level (BG) from the Navigator CGM. The goal level = 100.

Insulin starts at .5 units per hour. As the algorithm gets data from the CGM, it “learns” how successful it has been.

If the BG is less than 100, then Glucagon is administered. For adults, the general dosing is 10-15 units to raise BG 50 points. It uses this baseline to calculate glucagon dosing for how much below 100.

The other CGM’s are being used to document their accuracy so that the FDA and the manufacturers of those CGM’s can see how accurate they are. This information will be used to validate, or improve the systems.

Gladys? Really, David? Really?

Congratulations to those that choose Hope. You have earned bragging rights.